Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An autopsy case of a 65-year-old male who died of
hepatocellular carcinoma
superimposed on liver cirrhosis complicated with systemic sarcoidosis is presented. No organ metastasis of
hepatocellular carcinoma
was found except for a minute tumor embolus in the left upper lobe of the lung. Involved organs by sarcoidosis were the lymph nodes, lungs, heart, liver and spleen, but its presence was not noticed before death. Its cardiac involvement coincide with his clinical symptom of
exertional dyspnea
and the ECG finding of A-V block.
...
PMID:Hepatocellular carcinoma and myocardial sarcoidosis.--An autopsy case. 21 33
A 51-year-old man presented with
exertional dyspnea
for two months. He had a history of
hepatocellular carcinoma
that was totally resected three years earlier. Radionuclide angiocardiography disclosed a large photopenic area separating the heart from the liver, and lung blood pools mimicking a large pericardial effusion. Echocardiography and magnetic resonance imaging of the heart, however, showed extensive tumor infiltration of the myocardium of both ventricles. Endomyocardial biopsy confirmed the diagnosis of metastatic
hepatocellular carcinoma
. There was no evidence of recurrent
hepatoma
in the liver.
...
PMID:Cardiac metastasis of hepatocellular carcinoma mimicking pericardial effusion on radionuclide angiocardiography. 130 98
Available methodology was adapted to synthesize a labeled diether analog of 2-phosphatidylcholine (1,3-di-O-9'-cis-[9',10' (n)-3H]octadecenylglycero-2-phosphocholine [( 3H]
DOE
-2-PC). Unilamellar liposomes prepared by sonication from this phospholipid were injected into rats and, 4 h later, 65-78% of injected label was recovered in the liver. Thereafter, liver radioactivity disappeared with a half-life of 2-3 days. The radioactivity lost from the liver was recovered in the feces and in bile. Analysis of liver radioactivity showed that at all time intervals examined (4 h to 3 days after injection), 90% of the label remained as phospholipid. These findings provide evidence that this structural isomer is not readily metabolized, but is fairly rapidly eliminated from the liver. Of the 10% recovered as neutral lipid, 70% comigrated with diacylglycerol and 30% with triacylglycerol. Similar results were obtained when human
hepatoma
G2 cells in culture were incubated with [3H]
DOE
-2-PC liposomes. Following incubation of liposomes with liver homogenates, up to 10% conversion of [3H]
DOE
-2PC to neutral lipid occurred at pH 4.6, but not at pH 7.4. These data show that conversion of [3H]
DOE
-2-PC to dialkenylglycerol is catalyzed by a lysosomal enzyme. In separate experiments with cultured cells, sonicated dispersions of
DOE
-2-PC were mixed with high-density apolipoprotein and were shown to enhance markedly cellular cholesterol efflux. This novel diether phospholipid fulfills some of the criteria required of liposomes for their ability to remove cholesterol from the periphery as well as for drug delivery to the liver, i.e., stability in the circulation, marked hepatic uptake, slow metabolism, and elimination from the body.
...
PMID:Metabolic fate and effect on cholesterol removal of liposomes prepared from 1,3-di-O-octadecenylglycero-2-phosphocholine studied in vivo and in vitro. 367 42
Hepatocellular carcinoma
(
HCC
) is one of the most common neoplasma in Taiwan. The tumor itself has the tendency of extension into the venous system, such as to the portal vein, hepatic vein and inferior vena cava (IVC), but intra-atrial metastasis is unusual. Antemortem diagnosis was difficult before the availability of two-dimensional echocardiography (2-DE). Sometimes, the first symptoms and signs are cardiogenic manifestations such as
dyspnea on exertion
, syncope, edema of the lower legs, and shock. Clinicians may mistakenly make the wrong diagnosis of heart failure. Because of this, we hereby report three cases of
HCC
with right intra-atrial metastasis to raise the physician's awareness. All three cases initially presented as right side heart failure. Imaging study revealed
hepatocellular carcinoma
with right intra-atrial metastasis. Two of the three cases died within one month after diagnosis.
...
PMID:Hepatocellular carcinoma with metastasis to right atrium--a report of three cases. 747 37
Two patients with advanced
hepatocellular carcinoma
presented severe
exertional dyspnea
because of extension of a tumor into the right side of the heart. Removable of the tumor thrombus by open-heart surgery ameliorated the symptoms in each case, but their subsequent courses differed considerably. One patient survived for as long as 8 months thanks to successive multi-disciplinary treatments, whereas the other patient died suddenly 1 month after the surgery. The first patient's
hepatocellular carcinoma
was more differentiated, and the dyspnea was caused by a low cardiac output due to the intracardiac tumor mass, not by pulmonary embolism as in the second patient's case. We conclude that successive multidisciplinary treatments to control the growth of
hepatocellular carcinoma
is the most important approach and is indispensable for improving the prognosis.
...
PMID:Marked clinical improvement in patients with hepatocellular carcinoma by surgical removal of extended tumor mass in right atrium and pulmonary arteries. 813 87
Mediastinal invasion with pericardial involvement in
hepatocellular carcinoma
(
HCC
) is rarely described. We report two patients with hepatitis-C-related
HCC
, who, after several courses of transcatheter arterial chemoembolization (TACE), developed mediastinal and pericardial neoplastic growth. Both patients presented with clinical manifestations of
exertional dyspnea
, chest pain and orthopnea. The diagnosis of
HCC
with pericardial involvement, through direct invasion of the anterior mediastinum, was established by computerized tomography and magnetic resonance imaging. These patients' symptoms were relieved after they received radiotherapy with a total dosage of 3,000 and 4,000 cGy over a three-week and four-week period, respectively. We suggest that direct mediastinal invasion with pericardial involvement should be considered when evaluating patients with advanced
HCC
who developed precordial distress following palliative TACE. Early recognition of this unusual complication is important in the management of
HCC
.
...
PMID:Hepatocellular carcinoma with mediastinal and pericardial invasion: report of two cases. 1063 4
Pulmonary lymphangitic carcinomatosis is a well-documented phenomenon caused by spread of carcinoma to the pulmonary vasculature and lymphatics, often resulting in respiratory failure and cor pulmonale. It has been described in numerous types of carcinoma, most commonly occurring with carcinomas of the breast and stomach and with choriocarcinoma. We report the case of a patient who presented with increasing shortness of breath and
dyspnea on exertion
. Autopsy findings revealed diffuse pulmonary vascular spread of a
hepatocellular carcinoma
to the lungs. To our knowledge, this is the first reported case of lymphangitic spread of a
hepatocellular carcinoma
causing respiratory compromise (lymphangitic carcinomatosis).
...
PMID:Lymphangitic spread of hepatocellular carcinoma. 1256 85
A 74-year-old woman with a history of chronic hepatitis C and transcatheter arterial chemoembolization for an unresectable
hepatocellular carcinoma
(
HCC
) 2 years previously presented with progressive
exertional dyspnea
of 1 month's duration. Two-dimensional echocardiography revealed a huge right ventricular mass with right atrial and right ventricular outflow tract extension. Palliative resection of the tumor and adjunctive chemotherapy was performed. However, the right ventricular mass recurred 1 month later and the patient died 4 months after the operation. To our knowledge, this is the oldest patient reported with isolated right ventricular intracavitary metastasis of
HCC
, and this report reemphasizes the lower surgical indication in patients with metastatic cardiac tumors.
...
PMID:Isolated right ventricular intracavitary metastasis of hepatocellular carcinoma in a 74-year-old woman. 1856 64
We report a case of a man who developed duodenal bleeding caused by direct
hepatocellular carcinoma
(
HCC
) invasion, which was successfully treated with endoscopic ethanol injection. A 57-year-old man with known
HCC
was admitted for melena and
exertional dyspnea
. He had been diagnosed with inoperable
HCC
a year ago. Urgent esophagogastroduodenoscopy (EGD) showed two widely eroded mucosal lesions with irregularly shaped luminal protruding hard mass on the duodenal bulb. Argon plasma coagulation and Epinephrine injection failed to control bleeding. We injected ethanol via endoscopy to control bleeding two times with 14 cc and 15 cc separately without complication. Follow-up EGD catched a large ulcer with necrotic and sclerotic base but no bleeding evidence was present. He was discharged and he did relatively well during the following periods. In conclusion, Endoscopic ethanol injection can be used as a significantly effective and safe therapeutic tool in gastrointestinal tract bleeding caused by
HCC
invasion.
...
PMID:Endoscopic treatment of duodenal bleeding caused by direct hepatocellular carcinoma invasion with an ethanol injection. 2237 82
We report a 61-year-old male patient who presented with one month history of
exertional dyspnea
, persistent dry cough, abdominal pain with distension, poor appetite, and weight loss. This case illustrates a rare presentation of
hepatocellular carcinoma
with mobile right atrial thrombus and pulmonary embolism along with disseminated tumor thrombosis at multiple sites. Furthermore, this case reiterates that an early detection and diagnosis may have increasing importance in the advent of new therapies for treating advanced
hepatocellular carcinoma
.
...
PMID:Mobile right atrial thrombus with pulmonary thromboembolism in a patient with advanced hepatocellular carcinoma and disseminated tumor thrombosis. 2257 45
1
2
Next >>